These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 18458147)

  • 21. Cudratricusxanthone A Inhibits Lipid Accumulation and Expression of Inducible Nitric Oxide Synthase in 3T3-L1 Preadipocytes.
    Kwon HS; Jeong GS; Jang BC
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet.
    Kuda O; Jelenik T; Jilkova Z; Flachs P; Rossmeisl M; Hensler M; Kazdova L; Ogston N; Baranowski M; Gorski J; Janovska P; Kus V; Polak J; Mohamed-Ali V; Burcelin R; Cinti S; Bryhn M; Kopecky J
    Diabetologia; 2009 May; 52(5):941-51. PubMed ID: 19277604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice.
    Tsuchiya K; Sakai H; Suzuki N; Iwashima F; Yoshimoto T; Shichiri M; Hirata Y
    Endocrinology; 2007 Oct; 148(10):4548-56. PubMed ID: 17584959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.
    Gilardi F; Giudici M; Mitro N; Maschi O; Guerrini U; Rando G; Maggi A; Cermenati G; Laghezza A; Loiodice F; Pochetti G; Lavecchia A; Caruso D; De Fabiani E; Bamberg K; Crestani M
    J Biol Chem; 2014 Mar; 289(10):6908-6920. PubMed ID: 24451380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation.
    Hontecillas R; O'Shea M; Einerhand A; Diguardo M; Bassaganya-Riera J
    J Am Coll Nutr; 2009 Apr; 28(2):184-95. PubMed ID: 19828904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy.
    Kim JY; Jo KJ; Kim OS; Kim BJ; Kang DW; Lee KH; Baik HW; Han MS; Lee SK
    Life Sci; 2010 Sep; 87(11-12):358-66. PubMed ID: 20655933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.
    Prada PO; Ropelle ER; Mourão RH; de Souza CT; Pauli JR; Cintra DE; Schenka A; Rocco SA; Rittner R; Franchini KG; Vassallo J; Velloso LA; Carvalheira JB; Saad MJ
    Diabetes; 2009 Dec; 58(12):2910-9. PubMed ID: 19696185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response.
    Guo X; Li H; Xu H; Halim V; Thomas LN; Woo SL; Huo Y; Chen YE; Sturino JM; Wu C
    J Nutr Biochem; 2013 May; 24(5):770-5. PubMed ID: 22841546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt.
    Carvalho-Filho MA; Ropelle ER; Pauli RJ; Cintra DE; Tsukumo DM; Silveira LR; Curi R; Carvalheira JB; Velloso LA; Saad MJ
    Diabetologia; 2009 Nov; 52(11):2425-34. PubMed ID: 19730809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.
    Kim HJ; Jung TW; Kang ES; Kim DJ; Ahn CW; Lee KW; Lee HC; Cha BS
    Metabolism; 2007 May; 56(5):676-85. PubMed ID: 17445544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of lymphatic function and injury by nitrosative stress in obese mice.
    Rehal S; Kataru RP; Hespe GE; Baik JE; Park HJ; Ly C; Shin J; Mehrara BJ
    Mol Metab; 2020 Dec; 42():101081. PubMed ID: 32941994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
    Takasawa K; Kubota N; Terauchi Y; Kadowaki T
    Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality.
    Minge CE; Bennett BD; Norman RJ; Robker RL
    Endocrinology; 2008 May; 149(5):2646-56. PubMed ID: 18276752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.
    Choi JH; Banks AS; Estall JL; Kajimura S; Boström P; Laznik D; Ruas JL; Chalmers MJ; Kamenecka TM; Blüher M; Griffin PR; Spiegelman BM
    Nature; 2010 Jul; 466(7305):451-6. PubMed ID: 20651683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes.
    Jeon MJ; Leem J; Ko MS; Jang JE; Park HS; Kim HS; Kim M; Kim EH; Yoo HJ; Lee CH; Park IS; Lee KU; Koh EH
    Exp Mol Med; 2012 Sep; 44(9):562-70. PubMed ID: 22809900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivo.
    Ming Y; Hu X; Song Y; Liu Z; Li J; Gao R; Zhang Y; Mei H; Guo T; Xiao L; Wang B; Wu C; Xiao X
    PLoS One; 2014; 9(7):e102102. PubMed ID: 25004107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.
    González-Périz A; Horrillo R; Ferré N; Gronert K; Dong B; Morán-Salvador E; Titos E; Martínez-Clemente M; López-Parra M; Arroyo V; Clària J
    FASEB J; 2009 Jun; 23(6):1946-57. PubMed ID: 19211925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.